Open Access Open Access  Restricted Access Subscription Access

Formulation and Development of Rosuvastatin Fast Dissloving Tablets using Natural Super Disintegrates

M. Anusha, S. Varun Raj, P.V. Krishna Srewe, N. Divya Deepthi, Ch. Evanjiline, Ch. Roopa Koteswari

Abstract


Rosuvastatin is in category of the drug class. It is used to treat high cholesterol and to block cardiovascular disease. The main aim of this study is to develop oral dispersible tablets of Rosuvastatin using different types of super disintegrates to enhance the disintegration and dissolution of Rosuvastatin to improve bioavailability of the drug. Many trials were made to prepare a satisfactory rosuvastatin oral dispersible tablet using direct compression and wet granulation method. Formulate tablets were examine with different parameters such as weight variation, hardness, friability, wetting time, in vitro disintegration time, drug content, water absorption ratio and in vitro drug release. Formulas prepared by direct compression showed good flowability, while formulas were prepared by wet granulation showed with very poor flow properties. Numerous super disintegrates were used such as cross carmellose (CCS), sodium starch glycolate (SSG) and cross povidone (CP), then latter found to be the best in term of showing the fastest disintegration time. Among the two-diluents mannitol was found to be the best one in preparing rosuvastatin tablet with fastest disintegration time in mouth. The optimized selected formula (F11) was prepared by using 15% w/w cross povidone, by direct compression resulted that the shortest disintegration time in mouth (11 seconds), superior drug release profile [the time required for 80% of the drug to be released (t80%) and percent drug dissolved in 2 min (D2min) were 6 min. and 56 %respectively]. In addition to that the selected formula had shown acceptable hardness and friability, hence it is selected as the best formula. The overall results showed that cross povidone was the best super disintegrate of showing the shortest disintegration time while mannitol was the best diluent in preparing Rosuvastatin oral dispersible tablet and this suggested the possibility of utilizing the selected best formula (F11) in the preparation of Rosuvastatin oral dispersible tablet as a new dosage form for oral administration.

Full Text:

PDF

References


Erno A. van Schaik, Philippe Lechat, Bart M M. Remmerie, Grant Ko, Kenneth C. Lasseter, Eric Mannaert (2003), “Pharmacokinetic Comparison of Fast-Disintegrating and Conventional Tablet Formulations of Risperidone in Healthy Volunteers”, Clinical Therapeutics, Volume 25, Issue 6, pp. 1687−1699.

Suresh Bandari (2008), “Orodispersible tablets: An over view”, Asian J Pharm, Volume 1, pp. 1−5.

BognerRH, Wilkosz MF. (2002), “Fast Dissolving Tablets – New Dosage Convenience for Patients”, US Pharm, Volume 27, pp. 34−43.

Habib W, Khankari R, Hontz J. (2000), “Fast Dissolve Drug Delivery Systems”, Crit Rev Therap Car Sys, Volume 17, pp. 61−64.

Sastry SV, Nyshadham JR, Fix JA. (2000), “Recent Technological Advances in Oral Drug Delivery – A Review”, Pharm Sci Tech Today, Volume 3, pp. 138−144.

Kuchekar BS, Bhise SB, Arumugam V. (2001), “Design of Fast Dissolving Tablets”, Indian J Pharm Edu, Volume 35, Issue 4, pp. 150−154.

Devarajan, Padma V, Gore SP. (2000), “Melt in Mouth Tablets – Innovative Oral Drug Delivery Systems”, Express Pharma Pulse, Volume 7, Issue 1, pp. 16−18.

Reddy LH, GhoshBijaya, Rajneesh (2002), “Fast Dissolving Drug Delivery Systems: A Review of the Literature”, Ind J Pharm Sci, Volume 64, Issue 4, pp. 331−336.

Kaushik D, Dureja H, Saini TR (2004), “Mouth Dissolving Tablets – A Review”, Indian Drugs, Volume 41, Issue 4, pp. 187−193.

Indurwade NH, Rajyaguru TH, Nakhat PD. (2002), “Novel Approach – Fast Dissolving Tablets”, Indian Drugs, Volume 39, Issue 8, pp. 405−409.

Allen LV, Wang B, “Process for Making a particulate support matrix for making rapidly dissolving tablet”, US Patent No, 5, 587, 180:1996.

12 Allen LV, Wang B , Davis JD, “Method for Producing a Rapidly Dissolving Dosage Form”, US Patent No, 6, 066, 337:2000.

Vanscoik KG, “Solid Pharmaceutical Dosages in Tablet Triturate form and Method of Producing same”, US Patent No, 5, 082, 667:1992.

Pebely WS, Jager NE, “Thompson SJ. Rapidly Disintegrating Tablet”, US Patent No, 5, 298, 261:1994.

Makino T, Yamada M, Kikutata J, “Fast Dissolving Tablets and its Production”, US patent No, 5, 720, 974:1998.

CorveleynS, Remon JP. (1997), “Formulation and Production of Rapidly Disintegrating Tablets by Lyophilization using Hydrochlorothiazide as a Model Drug”, Int J Pharm, Volume 152, pp. 215−225.

Pather SI, Khankari RK, Eichman JD, Robinson JR, Hontz J. (2001), “Sublingual Buccal effervescent”, US Patent No, 6, 200, 604.

Arora Vimal, Gupta V.B, Singhal Rohit (2007), “Advances in direct compression technology”, Pharma Times, Volume 39, Issue 2, pp. 26−27.

Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR (2007), “Preparation and Assessment of Novel Coprocessed Superdisintegrant Consisting of Crospovidone and Sodium Starch Glycolate: A Technical Note”, APS PharmSciTech., Volume 8. Issue 1, Article 9.

S.B.Shirsand, R.G.Ramani, P.V.Swamy (2010), “Novelco-processed superdisintegrants in the design of fast dissolving tablets”, Int JPharma and Bio Sci, Volume 1, Issue 1, pp. 1−12.

Indian Pharmacopeia (2007), Ministry of Health and Family Welfare, Indian pharmacopeia Commission, Ghaziabad, Volume 2, 1381.

Goodman, Gilman (1786), “The pharmacological Basis of Therapeutics”, 9th Edition McGraw –Hill.

Young PM (2009), “Sodium starch glycolate”, In, Ray C Rowe, Paul JSheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical press, pp. 663−668.

Guest RT (2009), “Croscarmellose sodium”, In, Ray C Rowe, Paul JSheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical Press, pp. 206−208.

Kibbe AH. (2009), Crospovidone. In, Ray C Rowe, Paul JSheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical Press, pp. 208 −210.

Armstrong NA. (2009), “Sodium saccharin”, In, Ray C Rowe, Paul JSheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical press, pp. 424−428.

Guy A. (2009), “Microcrystalline cellulose”, In, Ray C Rowe, Paul JSheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical press, pp. 129−133.

Luner PE (2009), “Magnesium stearate”, In, Ray C Rowe, Paul J Sheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical press, pp. 404−408.

Kibbe AH (2009), Talc. In, Ray C Rowe, Paul JSheskey, Paul J Weller(ed), “Hand Book of Pharmaceutical excipients”, 6th edition, London, Pharmaceutical press, pp. 728−731.

Pilli Rohini, Maddumala Rajeswari, Hemasekhar M (2017), “Development and evalution of orodispersible tablets of Rosuvastatin calcium by β-Cyclodextrin inclusion complexes and using different superdisintegrants”, RJPBCS, Volume 8, Issue 5, pp. 529.


Refbacks

  • There are currently no refbacks.